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Summary.-Resistance to the cytocidal action of Adriamycin (ADR) was induced in
rat hepatocytes by incorporation of the carcinogen 2-acetylaminofluorene (AAF)
into the rat diet. Using a quantitative assay in primary monolayer culture, it was
demonstrated that resistance to ADR is an early phenotypic change that is induced
during chemical carcinogenesis in the rat, and appears to be stable.
THE CHEMOTHERAPY of disseminated
cancer in humans is based on the use of
a variety of toxins which are presumed to
be more toxic to malignant than to normal
cells (Burchenal, 1977). Cancer chemo-
therapeutic agents, which are often cyto-
toxins, act at many levels of cellular con-
trol, and have usually been designed to
interfere with the action of regulatory
macromolecules, including DNA and RNA
(Chabner etal., 1977) aswell aswith several
proteins (Abell et al., 1979). Although
these agents are often effective in inhibit-
ing the proliferation of transformed cells
in tissue culture or transplantable tumours
in animals, they appear to be less useful
in the treatment of many of the common
epithelial malignancies ofadults, as judged
by increase in overall patient survival
(DHEW Publication, 1976). Carcinogen-
altered, but not normal cells have in
general been shown to be resistant to the
toxic and antiproliferative effects of many
carcinogens (Vasiliev & Guelstein, 1963;
Diamond, 1969). It was therefore reasoned
that the clinical resistance of many epi-
thelial malignancies to the antiprolifera-
tive action of cytotoxic chemotherapy
might be a manifestation of a common
phenotypic change in carcinogen-treated
epithelial cells, namely, the ability to
resist the antiproliferative and cytocidal
effects of various toxins.
It has been previously shown that car-
cinogen-induced hyperplastic liver nodules
in the rat were resistant in vivo to the
acute effects of toxins which produced
necrosis in non-nodular liver (Farber et al.,
1976) and that hepatocytes of carcinogen-
fed rats were resistant both to the necro-
genic effects of aflatoxin B1 in vivo and
to the cytocidal effects of aflatoxin B1
in vitro, compared to control rats (Judah
et al., 1977). The resistance of carcinogen-
altered rat hepatocytes to the cytocidal
effects of various toxins is amenable to
quantitative study in vitro (Laishes et al.,
1978; Carr, 1980) using trypan-blue ex-
clusion as an end-point. This is necessary
because primary monolayer cultures of
normal adult rat hepatocytes do not pro-
liferate in vitro under the conditions which
are used.
We now show that rat hepatocytes
develop resistance to the cytocidal effect
of Adriamycin, when tested in vitro, very
soon after the dietary administration of
carcinogen. ADR is an anthracyclene
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antitumour antibiotic of particular
interest, because of the wide range of
human tumours that respond to its action
(Davis et al., 1978). Like many other
antineoplastic agents, it is highly necro-
genic (cytocidal) to normal tissues (Ignofo
& Friedman, 1980) in addition to its anti-
proliferative action. It has also been
demonstrated to be carcinogenic in the rat
(Marquardt et al., 1976).
MATERIALS AND METHODS
Animals and treatment.-Male Fischer-344
rats (Microbiological Associates or Charles
River Laboratory) weighing 150-200 g were
used. The animals were fed a basal, high-
casein diet (Bio-Serv), unless supplemented
by the carcinogen, 2-acetylaminofluorene
(AAF) as 0.02% (w/w), and were maintained
on a 12h light cycle in the animal colony.
Water A-as given ad libitum.
Primarymonolayercultures.-Liver-cell sus-
pensions were prepared by the proteolytic-
enzyme perfusion technique exactly as de-
scribedin Laishesetal. (1978). Cell suspensions
were passed through sterile gauze filters to
remove undissociated fragments, and viability
was assessed by trypan-blue exclusion. Cells
were plated at 106 viable cells per plastic
culture flask (Falcon plastics, 25 cm2 surface
area) in 4 ml of L-15 medium with Hepes
(3.5 mg/inl) and albumin (2 mg/ml) supple-
mented with 10% foetal bovine serum, peni-
cillin (100 1l/ml) and streptomycin (100 ,ug/
ml). After a 3h attachment period at 37°C
in a water-saturated 50/ CO2: 950o air incu-
bator, the cells were washed x 3 in the above
medium, and placed in 4 ml of the same
medium with or without (controls). ADR was
purchased from Adria Laboratories Inc.,
Columbus, Ohio. Stocks were made in saline
at 10 mg/ml, kept at 4°C, and discarded after
3 days.
Quantitation ofcell resistance
The monolayer cultures wAere incubated
with ADR or without (controls) for 24 h.
Then 0-8 ml of trypan blue was added to the
4 ml of medium in each flask and incubated
for 10 min at 37°C. After this, the medium
was removed and the number of viable (non-
staining) cells was counted. The percentage
ofresistant cells was expressed as the number
of viable, attached cells in the experimental
flasks compared to the number of viable,
attached cells in control flasks, which con-
tained the same cells but had no ADR in the
medium. Under these experimental condi-
tions, none of the cell types proliferate.
RESULTS
Male F344 rats weighing 150-200 g were
fed either a basal diet, or a basal diet
containing 0 02% (w/w) 2-acetylamino-
fluorene (AAF). This agent, when admin-
istered in the diet, acts as a mitotic in-
hibitor of normal rat hepatocytes (Solt
et al., 1977) and induces the formation of
both hyperplastic nodules and, later,
hepatocellular carcinomas (Wilson et al.,
1941). Macroscopic, subeapsular nodules
are grossly visible on the livers of rats
fed a diet containing 0.02% (w/w) AAF
for 12 weeks. Using a quantitative cyto-
toxicity assay with trypan blue exclusion
as the end-point (Laishes et al., 1978)
primary monolayer cultures ofhepatocytes
from rats fed either basal diet or basal
diet plus AAF for 12 weeks were examined
for resistance in vitro to the cytotoxic
effects of ADR (Fig. 1). It can be seen
that there is a three-log difference in the
LD50 for ADR when normal rat hepato-
cytes (3 x 10-7M ADR) are compared to
hepatocytes which are altered by the
feeding of AAF (4 x 10-4M ADR). The
figures represent the averages (± s.d.)
for 3 normal and 3 carcinogen-fed rats.
For each animal, 3 flasks were counted
for each drug concentration, and the
average number of cells in 15 fields of
view was computed. Control flasks demon-
strated that attachment efficiencies were
similar for both normal and carcinogen-
altered hepatocytes, and ranged from 65
to 80%. Selective detachment did not
occur either, since no more than 15%0 of
floating cells were found in control flasks
for either cell type at 24 h.
The duration of carcinogen feeding
needed for production of the resistant
hepatocyte phenotype was determined.
Rats were placed on the AAF diet and
killed at intervals after the start of car-
568CARCINOGEN-INDUCED DRUG RESISTANCE
100 E
80 T
60~~~~~~~~~~~~~~~~~~~~
60 _IT
40
20 TE\
T
I I I I I I I~~111 -LA I Ir- r M-4-,-l.-... Ii 111
lo-8 10-7 10-6 10-5 lo-4 10-3 1C
ADRIAMYCIN CONCENTRATION (M)
Fia. 1.-A comparison of the proportion of ADR-resistant liepatocytes culturedl from normal
rat liver (D O -) or from the livers of rats fed the carcinogen, AAF (0 0). Eaclh point represents
the mean (± s.d.) of 3 experiments. Each experiment used 3 flasks. Survival of attaclhed viable
cells as % ofcontrols after 24 li exposure to ADR.
cinogen feeding. The hepatocytes were
then harvested and placed in primary
monolayer culture, and the percentage
of surviving cells in the presence of ADR
1 8 x 10-4M was measured, compared to
the control flasks without ADR (as
described above). Fig. 2a represents the
results of 3 experiments, and shows that
the carcinogen-induced resistance to the
cytocidal action of ADR, as measured
in vitro, had appeared after 24 h of car-
cinogen feeding (Fig. 2a). Furthermore,
most of the increase in resistance occurred
by 1 week of continuous feeding of car-
cinogen, and did not decrease with time.
In order to estimate the stability of
the carcinogen-induced, resistant pheno-
type, rats were fed an AAF-containing
diet and then killed after return to a basal,
non-carcinogenic diet. Fig. 2b illustrates
the pattern of resistance after 4 weeks of
continuous carcinogen administration in
the diet, and a subsequent return to a
carcinogen-free diet. Each point represents
the average (± s.d.) for 3 rats. It can be
seen that for a further 2 months there is
little loss of resistance to the cytocidal
effects ofADR, as measured in rat hepato-
cytes in vitro.
DISCt SS1ON
The toxicity of many carcinogens led
Haddow (1938) to suggest that in response
to carcinogen-induced inhibition ofnormal
cell proliferation a new cell type is formed
which may grow even in the presence of
toxic carcinogens. The differential resis-
tance ofcarcinogen-altered cells to toxicity
by carcinogens was the basis of a clonal-
selection theory of cancer (Prehn, 1964)
and experimental support for these ideas
has recently included the ability of car-
cinogen-altered cells to proliferate selec-
tively in vivo in a carcinogen-induced,
toxic environment (Solt & Farber, 1976).
The experiments reported here show that
hepatocytes from AAF-treated rats are
resistant to the cytocidal effects of the
anthracyclene antibiotic ADR at concen-
trations which are toxic to hepatocytes
from normal rats. Resistance occurs very
early in hepatocarcinogenesis, even before
new cell populations have developed (Laws
et al., 1952; Farber, 1956). However, the
stability of the ADR resistant phenotype
observed in the present study could be
attributed, at least in part, to new cell
populations that have developed in this
time (Laws et al., 1952; Farber, 1956).
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FIG. 2.-A-Theappearance ofADR-resistant
cells during dietary administration of the
carcinogen, AAF.
B-The stability of AAF-induced resis-
tance in vitro. Entire line represents the
resistance of hepatocytes from rats re-
ceiving dietary AAF (0-020% w/w); The
broken line represents the resistance of
hepatocytes from rats after return to a basal
AAF-free diet.
Each experimental point in A and B
represents the mean + s.d. of 2 experiments,
each using 3 flasks. The dosage of ADR
was 1-8 x 10-4M.
The significance of these observations
is not yet clear. A high proportion of the
cell population exhibits the resistant
phenotype, and presumably not all of
these cells participate in the carcinogenic
process. However, presumptive preneo-
plastic cells, staining positively for the
marker y-glutamyltranspeptidase, com-
prise about 44%0 of hepatocytes after 14
weeks of feeding a diet containing AAF,
which is several months before the appear-
ance ofcancer. In addition, there are many
more hyperplastic nodulesthansubsequent
cancers. Whether these represent different
subpopulations of carcinogen-altered cells
remains to be determined. The proportion
of cells in a given organ which are capable
of developing into cancer during chronic
carcinogen administration isalsounknown.
However, the relatively short lifespan of
rodents and the death from the effects
of one or few foci of cancer lead to diffi-
culties in devising experiments on these
issues.
If these observations reflect some of the
changes that occur in the early develop-
ment of human hepatocellular carcinoma
(HCC), then HCC cells would appear to be
particularly adept at resisting the cyto-
cidal effects of a variety of cytotoxins,
including Adriamycin. Current experi-
ments are focusing on the mechanisms
likely to be responsible for the carcinogen-
induced resistance. These include a car-
cinogen-induced alteration in the mem-
brane transport for ADR; a decrease in
the microsome-mediated activation of
ADR to its superoxide forms; an increased
catabolism to inactive ADR metabolites;
or the induction by the carcinogen of
cellular mechanisms for abrogating the
toxic effects of active radicals of ADR,
which might include glutathione, catalase,
peroxidases and superoxide dismutase.
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